Transcriptional networks in developing and mature B cells

Nature Reviews Immunology

Volumn 5, Issue 6, 2005, Pages 497-508

  Matthias, Patrick ^a   Rolink, Antonius G ^b  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; CD45 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; DNA; DNA BINDING PROTEIN; DNA NUCLEOTIDYLEXOTRANSFERASE; EARLY B CELL FACTOR; EPIDERMAL GROWTH FACTOR; HIGH MOBILITY GROUP PROTEIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; LEUKOSIALIN; LYMPHOID ENHANCER FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; RAG1 PROTEIN; RAG2 PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG;

ANIMAL CELL; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HIGH MOBILITY GROUP BOX DOMAIN; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; B-LYMPHOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOPOIESIS; PLASMA CELLS; TRANSCRIPTION FACTORS;

EID: 20644461729     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1633     Document Type: Review

References (114)

1. Medina, K. L. et al. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nature Immunol. 2, 718-724 (2001).
2. Igarashi, H., Gregory, S. C., Yokota, T., Sakaguchi, N. & Kincade, P. W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17, 117-130 (2002).
3. Allman, D. et al. Thymopoiesis independent of common lymphoid progenitors. Nature Immunol. 4, 168-174 (2003).
4. Martin, C. H. et al. Efficient thymic immigration of B220-lymphoid- restricted bone marrow cells with T precursor potential. Nature Immunol. 4, 866-873 (2003).
5. Loffert, D., Ehlich, A., Muller, W. & Rajewsky, K. Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development. Immunity 4, 133-144 (1996).
6. Shimizu, T., Mundt, C., Licence, S., Melchers, F. & Martensson, I. L VpreB1/VpreB2/λ5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus. J. Immunol. 168, 286-6293 (2002).
7. Nemazee, D. & Weigert, M. Revising B cell receptors. J. Exp. Med 191, 1813-1817 (2000).
8. Loder, F. et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190, 75-89 (1999).
9. Montecino-Rodriguez, E., Leathers, H. & Dorshkind, K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nature Immunol. 2, 83-88 (2001).
10. McKercher, S. R. et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658 (1996).
11. Scott, E. W., Simon, M. C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577 (1994). This was the first study to show that PU.1 is required for the earliest stages of lymphocyte development
12. Scott, E. W. et al. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 6, 437-447 (1997).
13. DeKoter, R. P., Walsh, J. C. & Singh, H. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 17, 4456-4468 (1998).
14. DeKoter, R. P., Lee, H. J. & Singh, H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16, 297-309 (2002).
15. Schweitzer, B. L. & DeKoter, R. P. Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines. J. Immunol. 172, 144-154 (2004).
16. Su, G. H. et al. Defective B cell receptor-mediated responses in mice lacking the EtS protein, Spi-B. EMBO J. 16, 7118-7129 (1997).
17. Dahl, R., Ramirez-Bergeron, D. L., Rao, S. & Simon, M. C. Spi-B can functionally replace PU.1 in myeloid but not lymphoid development. EMBO J. 21, 2220-2230 (2002).
18. DeKoter, R. P. & Singh, H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288, 1439-1441 (2000).
19. Rosenbauer, F. et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nature Genet. 36, 624-630 (2004).
20. Georgopoulos, K., Winandy S. & Avitahl, N. The role of the Ikaros gene in lymphocyte development and homeostasis. Annu. Rev. Immunol. 15, 155-176 (1997).
21. Kelley, C. M. et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr. Biol. 8, 508-515 (1998).
22. Morgan, B. et al. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16, 2004-2013 (1997).
23. Koipally, J., Renold, A., Kim, J. & Georgopoulos, K. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 18, 3090-3100 (1999).
24. Kim, J. et al. Ikaros DMA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10, 345-355 (1999).
25. Georgopoulos, K. et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79, 143-156 (1994). This work showed the crucial role of Ikaros for the generation of all lymphocytic lineages.
26. Wang, J. H. et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5, 537-549 (1996).
27. Nichogiannopoulou, A., Trevisan, M., Neben, S., Friedrich, C. & Georgopoulos, K. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190, 1201-1214 (1999).
28. Kirstetter, P., Thomas, M., Dierich, A., Kastner, P. & Chan, S. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32, 720-730 (2002).
29. Papathanasiou, P. et al. Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. Immunity 19, 131-144 (2003). This Interesting paper showed that an Ikaros gene with a point mutation In the region encoding the DNA-binding domain has a stronger phenotype in mice than a null mutant, presumably because it inactivates several Ikaros-containing complexes.
30. + thymocytes by Ikaros proteins in direct competition with an EtS activator. Genes Dev. 15, 1817-1832 (2001).
31. Sabbattini, P. et al. Binding of Ikaros to the λ5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J. 20, 2812-2822 (2001).
32. Harker, N. et al. The CD8α gene locus is regulated by the Ikaros family of proteins, Mol. Cell 10, 1403-1415 (2002).
33. Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885-892 (1994). This paper, together with references 37 and 41, was the first to identify the crucial role of E2A proteins in the earliest stages of B-cell development.
34. Kee, B. L., Quong, M. W. & Murre, C. E2A proteins: essential regulators at multiple stages of B-cell development. Immunol. Rev. 175, 138-149 (2000).
35. Bain, G. et al. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17, 4782-4791 (1997).
36. Zhuang, Y., Jackson, A., Pan, L., Shen, K. & Dai, M. Regulation of E2A gene expression in B-lymphocyte development. Mol. Immunol. 40, 1165-1177 (2004).
37. Zhuang, Y., Soriano, P. & Weintraub, H. The helix-loop-helix gene F24 is required for B cell formation. Cell 79, 875-884 (1994).
38. Massari, M. E. et al. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell 4, 63-73 (1999).
39. Zhuang, Y., Cheng, P. & Weintraub, H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16, 2898-2905 (1996).
40. Zhuang, Y., Barndt, R. J., Pan, L., Kelley, R. & Dai, M. Functional replacement of the mouse E2A gene with a human HEB cDNA. Mol. Cell. Biol. 18, 3340-3349 (1998).
41. Sun, X. H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79, 893-900 (1994).
42. Hagman, J., Gutch, M. J., Lin, H. & Grosschedl, R. EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains. EMBO J. 14, 2907-2916 (1995).
43. Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263-267 (1995). The was the first report to identify the crucial role of EBF at the pro-B-cell stage of development.
44. Seet, C. S., Brumbaugh, R. L. & Kee, B. L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199, 1689-1700 (2004).
45. Smith, E. M., Gisler, R. & Sigvardsson, M. Cloning and characterization of a promoter flanking the early B cell factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression. J. Immunol. 169, 261-270 (2002).
46. O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21-31 (1999).
47. Sigvardsson, M., O'Riordan, M. & Grosschedl, R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7, 25-36 (1997).
48. Romanow, W. J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 343-353 (2000).
49. Medina, K. L. et al. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7, 607-617 (2004).
50. Sigvardsson, M. et al. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter. Mol. Cell. Biol. 22, 8539-8551 (2002).
51. Maier, H. et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mob-1 transcription. Nature Immunol. 5, 1069-1077 (2004). This interesting paper describes the hierarchical involvement of RUNX1 and EBF in activation of the Mb-1 promoter, allowing PAX5, in turn, to activate the Mb-1 gene. The data presented agree with the model proposed in reference 49, which describes the genetic control of pre-B-cell specification.
52. Nutt, S. L., Morrison, A. M., Dorter, P., Rolink, A. & Busslinger, M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17, 2319-2333 (1998).
53. Urbanek, P., Wang, Z. Q., Fetka, I., Wagner, E. F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901-912 (1994).
54. Kosak, S. T. et al. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296, 158-162 (2002).
55. Fuxa, M. et al. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18, 411-422 (2004).
56. Nutt, S. L., Heavey, B., Rolink, A. G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556-562 (1999).
57. -/- B cells can have alternative cell fates, such as development into T cells or macrophages.
58. Schaniel, C., Bruno, L., Melchers, F. & Rolink, A. G. Multiple hematopoietic cell lineages develop in vivo from transplanted Rax5-deficient pre-BI-cell clones. Blood 99, 472-478 (2002).
59. Mikkola, I., Heavey, B., Horcher, M. & Busslinger, M. Reversion of B cell commitment upon loss of Pax5 expression. Science 297, 110-113 (2002). This paper elegantly showed that ablation of PAX5 in already committed pro-B cells allows these cells to regain plasticity and differentiate into diverse cell types, such as T cells or macrophages.
60. Horcher, M., Souabni, A. & Busslinger, M. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14, 779-790 (2001).
61. Souabni, A., Cobaleda, C., Schebesta, M. & Busslinger, M. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17, 781-793 (2002).
62. Eberhard, D., Jimenez, G., Heavey, B. & Busslinger, M. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J. 19, 2292-2303 (2000).
63. Linderson, Y. et al. Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes. EMBO Rep. 5, 291-296 (2004).
64. Radtke, F., Wilson, A., Mancini, S. J. & MacDonald, H. R. Notch regulation of lymphocyte development and function. Nature Immunol. 5, 247-253 (2004).
65. Hoflinger, S. et al. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors. J. Immunol. 173, 3935-3944 (2004).
66. Xie, H., Ye, M., Feng, R. & Graf, T. Stepwise reprogramming of B cells into macrophages. Cell 117, 663-676 (2004).
67. Schilham, M. W. et al. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 380, 711-714 (1996).
68. Schilham, M. W. & Clevers, H. HMG box containing transcription factors in lymphocyte differentiation. Semin. Immunol. 10, 127-132 (1998).
69. Staal, F. J. & Clevers, H. C. WNT signalling and haematopoiesis: a WNT-WNT situation. Nature Rev. Immunol. 5, 21-30 (2005).
70. Reya, T. et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13, 15-24 (2000).
71. Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655 (2001).
72. Mittrucker, H. W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540-543 (1997).
73. Holtschke, T. et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307-317 (1996).
74. Lu, R., Medina, K. L., Lancki, D. W. & Singh, H. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17, 1703-1708 (2003).
75. Sun, J., Matthias, G., Mihatsch, M. J., Georgopoulos, K. & Matthias, P. Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice. J. Immunol. 170, 1699-1706 (2003).
76. Shapiro-Shelef, M. & Calame, K. Regulation of plasma-cell development. Nature Rev. Immunol. 5, 230-242 (2005).
77. Boehm, J., He, Y., Greiner, A., Staudt, L. & Wirth, T. Regulation of BOB.1/OBF.1 stability by SIAH. EMBO J. 20, 4153-4162 (2001).
78. Tiedt, R., Bartholdy, B. A., Matthias, G., Newell, J. W. & Matthias, P. The RING finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1. EMBO J. 20, 4143-4152 (2001).
79. Yu, X., Wang, L., Luo, Y. & Roeder, R. G. Identification and characterization of a novel OCA-B isoform: implications for a role in B cell signaling pathways. Immunity 14, 157-167 (2001).
80. Corcoran, L. M. et al. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7, 570-582 (1993).
81. Kim, U. et al. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383, 542-547 (1996).
82. Nielsen, P. J., Georgiev, O., Lorenz, B. & Schaffner, W. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 26, 3214-3218 (1996).
83. Schubart, D. B., Rolink, A., Kosco-Vilbois, M. H., Botteri, F. & Matthias, P. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 383, 538-542 (1996). References 81-83 showed that the co-activator OBF1 is not essential for immunoglobulin gene transcription but rather for robust humoral immune responses and germinal-centre formation. In addition, reference 85 showed that immunoglobulin gene transcription is normal even when OBF1 and OCT2 are both absent.
84. Matthias, P. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what? Semin. Immunol. 10, 155-163 (1998).
85. Schubart, K. et al. B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. Nature Immunol. 2, 69-74 (2001).
86. Casellas, R. et al. OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin κ genes. Cell 110, 575-585 (2002).
87. Wang, J. H. et al. Aiolos regulates B cell activation and maturation to effector state. Immunity 9, 543-553 (1998).
88. Hess, J., Nielsen, P. J., Fischer, K. D., Bujard, H. & Wirth, T. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol. Cell. Biol. 21, 1531-1539 (2001).
89. Schubart, D. B., Rolink, A., Schubart, K. & Matthias, P. Lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Burton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1. J. Immunol. 164, 18-22 (2000).
90. Samardzic, T., Marinkovic, D., Nielsen, P. J., Nitschke, L. & Wirth, T. BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol. Cell. Biol. 22, 8320-8331 (2002).
91. Corcoran, L. M. & Karvelas, M. Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation. Immunity 1, 635-645 (1994).
92. Humbert, P. O. & Corcoran, L. M. Oct-2 gene disruption eliminates the peritoneal B-1 lymphocyte lineage and attenuates B-2 cell maturation and function. J. Immunol. 159, 5273-5284 (1997).
93. Wang, V. E., Tantin, D., Chen, J. & Sharp, P. A. B cell development and immunoglobulin transcription in Oct-1-deficient mice. Proc. Natl Acad. Sci. USA 101, 2005-2010 (2004).
94. Ghosh, S., May, M. J. & Kopp, E. B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260 (1998).
95. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81-S96 (2002).
96. Hayden, M. S. & Ghosh, S. Signaling to NF-κB. Genes Dev. 18, 2195-2224 (2004).
97. Sha, W. C., Liou, H. C., Tuomanen, E. I. & Baltimore, D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330 (1995). This was the first study to identify the multiple in vivo roles of NF-κB. This paper also revealed that NF-κB is not required for Igκ light-chain rearrangement and transcription.
98. Cariappa, A., Liou, H. C., Horwitz, B. H. & Pillai, S. Nuclear factor κB is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192, 1175-1182 (2000).
99. L. Mol. Cell. Biol. 20, 2687-2695 (2000).
100. Hsu, B. L., Harless, S. M., Lindsley, R. C., Hilbert, D. M. & Cancro, M. P. BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol. 168, 5993-5996 (2002).
101. Weih, D. S., Yilmaz, Z. B. & Weih, F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167, 1909-1919 (2001).
102. Franzoso, G. et al. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11, 3482-3496 (1997).
103. Grossmann, M. et al. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19, 6351-6360 (2000).
104. Cariappa, A. et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14, 603-615 (2001). This paper proposed a model in which the level of BCR signalling is a key determinant of differentiation into marginal-zone B cells, and it identified Aiolos as one of the essential factors in this process.
105. Radtke, R et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547-558 (1999).
106. Tanigaki, K. et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nature Immunol. 3, 443-450 (2002).
107. Kuroda, K. et al. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 18, 301-312 (2003).
108. Saito, T. et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18, 675-685 (2003).
109. Garrett-Sinha, L. A. et al. PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 10, 399-408 (1999).
110. Hu, C. J. et al. PU.1/Spi-B regulation of c-rel is essential for mature B cell survival. Immunity 15, 545-555 (2001).
111. Bergman, Y. & Cedar, H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nature Rev. Immunol. 4, 753-761 (2004).
112. Schwarz, B. A. & Bhandoola, A. Circulating hematopoietic progenitors with T lineage potential. Nature Immunol. 5, 953-960 (2004).
113. Hardy, R. R. & Hayakawa, K. B cell development pathways. Annu. Rev. Immunol. 19, 595-621 (2001).
114. Sugai, M. et al. Essential role of Id2 in negative regulation of IgE class switching. Nature Immunol. 4, 25-30 (2002).